[ad_1]
The Critical Path Institute (C-Path) Consortium Critical Path for Alzheimer’s Disease (CPAD) announced today its participation as a partner in the Alzheimer’s Disease Data Initiative (ADDI), a 501 (c) (3) medical research organization that launched today .
ADDI is dedicated to promoting scientific advances in the treatment of Alzheimer’s disease (AD) and related dementias.
ADDI will be a game-changing collaboration to provide the data accessibility needed to advance data-driven solutions to accelerate drug development for Alzheimer’s disease. C-Path is honored to be a key partner of ADDI, through CPAD, and to contribute our data science, model-driven drug development, and regulatory science expertise to ensure the success of ADDI.. “
Klaus Romero, MD, MS, FCP, Scientific Director, Critical Path Institute (C-Path)
CPAD’s integrated and standardized patient-level database comprised of industry randomized clinical trials, currently available to qualified researchers worldwide, will be a relevant and crucial component of the Alzheimer’s Disease Workbench. ADDI.
This will enable AD and related dementia researchers around the world to interact with relevant data resources more efficiently and accelerate the generation of actionable scientific insights leading to innovative solutions, diagnostic tools and therapies in AD.
Emphasizing the expected impact of ADDI, CPAD Executive Director Sudhir Sivakumaran, Ph.D., said: “ADDI is uniquely positioned to maximize the value of each data point contributed by people living with AD, who participate in clinical trials, registry studies and other research efforts. “
CPAD Industrial Co-Director and Vice President, Clinical Research, Neurology Business Group, Eisai, Inc. Michael C. Irizarry, MD, MPH, added: “In this important initiative, CPAD’s partnership with ADDI aims to facilitate further aggregation. and robust analysis of high-quality AD clinical research data to model disease progression and help accelerate the development of biomarkers and therapies. “
Source:
Critical Path Institute (C-Path)
